Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Bidirectional, Absorbable, No-Drain Abdominoplasty.
Journal: Aesthetic plastic surgery
Published: July 20, 2017
Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 13, 2016
A Phase I Clinical Trial and Independent Patient-Derived Xenograft Study of Combined Targeted Treatment with Dacomitinib and Figitumumab in Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 23, 2015
Rhytidectomy Utilizing Bidirectional Self-Retaining Sutures: The Bidirectional Lift and the Extended Bidirectional Lift.
Journal: Aesthetic surgery journal
Published: August 01, 2015
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial.
Journal: The Lancet. Oncology
Published: December 03, 2014
Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial.
Journal: The Lancet. Oncology
Published: December 03, 2014
Reply to M.C. Garassino et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 26, 2013
Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 04, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026